Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance neomycin is replaced by the following:

Pharmacologically active substance Marker residue Animal Species MRL Target Tissues Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Neomycin (including framycetin) Neomycin B All food producing species 500 μg/kg Muscle
For fin fish the muscle MRL relates to “muscle and skin in natural proportions”.

MRLs for fat, liver and kidney do not apply to fin fish.

For porcine and poultry species the fat MRL relates to “skin and fat in natural proportions”
Anti-infectious agents/Antibiotics’
500 μg/kg Fat
5 500 μg/kg Liver
9 000 μg/kg Kidney
1 500 μg/kg Milk
500 μg/kg Eggs

Pharmacologically active substance	Marker residue	Animal Species	MRL	Target Tissues	Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Neomycin (including framycetin)	Neomycin B	All food producing species	500 μg/kg	Muscle	For fin fish the muscle MRL relates to “muscle and skin in natural proportions”. MRLs for fat, liver and kidney do not apply to fin fish. For porcine and poultry species the fat MRL relates to “skin and fat in natural proportions”	Anti-infectious agents/Antibiotics’
			500 μg/kg	Fat
			5 500 μg/kg	Liver
			9 000 μg/kg	Kidney
			1 500 μg/kg	Milk
			500 μg/kg	Eggs